A detailed history of Atlas Capital Advisors LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,555 shares of ELV stock, worth $1.79 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
4,555
Previous 4,247 7.25%
Holding current value
$1.79 Million
Previous $2.3 Billion 2.93%
% of portfolio
0.36%
Previous 0.3%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$500.12 - $562.29 $154,036 - $173,185
308 Added 7.25%
4,555 $2.37 Billion
Q2 2024

Jul 29, 2024

SELL
$497.49 - $547.8 $172,629 - $190,086
-347 Reduced 7.55%
4,247 $2.3 Billion
Q1 2024

Apr 15, 2024

SELL
$464.61 - $519.96 $12,544 - $14,038
-27 Reduced 0.58%
4,594 $2.38 Billion
Q4 2023

Feb 15, 2024

BUY
$433.51 - $488.06 $73,696 - $82,970
170 Added 3.82%
4,621 $2.18 Billion
Q2 2023

Aug 15, 2023

SELL
$436.33 - $496.2 $20,071 - $22,825
-46 Reduced 1.02%
4,451 $1.98 Billion
Q1 2023

May 16, 2023

SELL
$446.3 - $502.2 $290,095 - $326,430
-650 Reduced 12.63%
4,497 $2.07 Billion
Q4 2022

Feb 15, 2023

BUY
$465.23 - $546.77 $192,139 - $225,816
413 Added 8.72%
5,147 $2.64 Billion
Q3 2022

Nov 08, 2022

BUY
$445.98 - $507.0 $891 - $1,014
2 Added 0.04%
4,734 $2.15 Billion
Q2 2022

Aug 16, 2022

SELL
$444.32 - $529.84 $8,886 - $10,596
-20 Reduced 0.42%
4,732 $2.28 Billion
Q1 2022

May 11, 2022

BUY
$428.44 - $502.48 $357,318 - $419,068
834 Added 21.29%
4,752 $2.33 Billion
Q4 2021

Feb 01, 2022

SELL
$370.08 - $467.67 $176,528 - $223,078
-477 Reduced 10.85%
3,918 $1.82 Billion
Q3 2021

Oct 28, 2021

SELL
$357.51 - $398.13 $16,445 - $18,313
-46 Reduced 1.04%
4,395 $1.64 Million
Q2 2021

Jul 30, 2021

BUY
$352.19 - $401.9 $97,908 - $111,728
278 Added 6.68%
4,441 $1.7 Million
Q1 2021

May 10, 2021

SELL
$287.7 - $371.31 $481,609 - $621,572
-1,674 Reduced 28.68%
4,163 $1.49 Million
Q4 2020

Feb 16, 2021

BUY
$270.17 - $333.15 $12,697 - $15,658
47 Added 0.81%
5,837 $1.87 Million
Q3 2020

Oct 23, 2020

SELL
$245.73 - $284.63 $52,831 - $61,195
-215 Reduced 3.58%
5,790 $1.56 Million
Q2 2020

Jul 28, 2020

BUY
$203.3 - $300.59 $14,027 - $20,740
69 Added 1.16%
6,005 $1.58 Million
Q1 2020

May 04, 2020

SELL
$174.68 - $307.74 $27,599 - $48,622
-158 Reduced 2.59%
5,936 $1.35 Million
Q4 2019

Jan 28, 2020

SELL
$234.82 - $306.42 $113,652 - $148,307
-484 Reduced 7.36%
6,094 $1.84 Million
Q3 2019

Nov 01, 2019

BUY
$237.69 - $310.48 $366,280 - $478,449
1,541 Added 30.59%
6,578 $1.58 Million
Q2 2019

Jul 25, 2019

BUY
$236.25 - $293.76 $12,285 - $15,275
52 Added 1.04%
5,037 $0
Q1 2019

Apr 29, 2019

SELL
$248.42 - $317.42 $504,292 - $644,362
-2,030 Reduced 28.94%
4,985 $0
Q4 2018

Jan 29, 2019

SELL
$249.0 - $296.25 $164,091 - $195,228
-659 Reduced 8.59%
7,015 $1.84 Million
Q3 2018

Nov 09, 2018

BUY
$238.27 - $274.12 $361,455 - $415,840
1,517 Added 24.64%
7,674 $0
Q2 2018

Jul 30, 2018

SELL
$220.13 - $245.16 $737,215 - $821,040
-3,349 Reduced 35.23%
6,157 $0
Q1 2018

Apr 18, 2018

BUY
$215.63 - $258.19 $2.05 Million - $2.45 Million
9,506 New
9,506 $0

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $94.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.